Ikos Cif Ltd adds Monsanto Company (MON) to its portfolio

Monsanto Company (MON) : Ikos Cif Ltd added new position in Monsanto Company during the most recent quarter end. The investment management firm now holds 7,403 shares of Monsanto Company which is valued at $739,856 , the company said in a statement filed on May 13, 2016 with the SEC.Monsanto Company makes up approximately 1.76% of Ikos Cif Ltd’s portfolio.

Other Hedge Funds, Including , Tetrem Capital Management Ltd. boosted its stake in MON in the latest quarter, The investment management firm added 65,856 additional shares and now holds a total of 324,984 shares of Monsanto Company which is valued at $32.5 Million. Monsanto Company makes up approx 1.29% of Tetrem Capital Management Ltd.’s portfolio. Amf Pensionsforsakring Ab sold out all of its stake in MON during the most recent quarter. The investment firm sold 4,230 shares of MON which is valued $422,746.Exane Derivatives reduced its stake in MON by selling 131 shares or 94.93% in the most recent quarter. The Hedge Fund company now holds 7 shares of MON which is valued at $628.Aperio Group reduced its stake in MON by selling 1,409 shares or 1.03% in the most recent quarter. The Hedge Fund company now holds 135,757 shares of MON which is valued at $12.7 Million. Monsanto Company makes up approx 0.11% of Aperio Group’s portfolio.

Monsanto Company opened for trading at $111.42 and hit $113 on the upside on Wednesday, eventually ending the session at $111.68, with a gain of 2.18% or 2.38 points. The heightened volatility saw the trading volume jump to 1,31,67,916 shares. Company has a market cap of $48,787 M.

On the company’s financial health, Monsanto Company reported $2.42 EPS for the quarter, based on the information available during the earnings call on Apr 6, 2016. Analyst had a consensus estimate of $2.42. The company had revenue of $4532.00 million for the quarter, compared to analysts expectations of $4734.36 million. The company’s revenue was down -12.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.90 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016. Shares were Reiterated by Deutsche Bank on Apr 7, 2016 to “Buy” and Lowered the Price Target to $ 100 from a previous price target of $105 .Monsanto Company was Downgraded by Citigroup to ” Neutral” on Mar 14, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.